DOUGLAS AG/ DE000BEAU7Y1 /
| 2024-05-29 5:36:05 PM | Chg. -0.580 | Volume | Bid2024-05-29 | Ask5:36:05 PM | High | Low |
|---|---|---|---|---|---|---|
| 19.760EUR | -2.85% | 92,046 Turnover: 1.83 mill. |
-Bid Size: - | -Ask Size: - | 20.700 | 19.600 |
GlobeNewswire
3:00 PM
AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Change...
GlobeNewswire
2:01 PM
The insurance industry has big ambitions for analytics but struggles to realize benefits as progress...
GlobeNewswire
05-28
Bannix Acquisition Corp. Receives NASDAQ Notification of Non-Compliance with Listing Rules
GlobeNewswire
05-23
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spec...
GlobeNewswire
05-17
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
GlobeNewswire
05-17
Calibre Announces Proposed Update to its Board of Directors and Change to Senior Management
GlobeNewswire
05-14
Market improves as premiums begin to stabilize in the Commercial Insurance Marketplace
GlobeNewswire
05-14
ManTech Wins $110 Million Air Force Contract for Human Capital Transformation and AI
GlobeNewswire
05-10
SMATL LTD. (SMA EXCHANGE smatl.com) has successfully registered with the SEC and initiated a series ...
GlobeNewswire
05-09
America’s Mutual Banks Announces Annual Financial Analysis of the Mutual Thrift Industry: Commitment...
GlobeNewswire
05-07
Midland States Bancorp, Inc. Announces Common Stock and Preferred Stock Dividends
GlobeNewswire
05-07
Verita adds new Workers’ Compensation solution to its suite of casualty products
GlobeNewswire
05-06
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax...
GlobeNewswire
05-02
Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Dru...
